Cargando…
A subset of VEGFR‐TKIs activates AMPK in LKB1‐mutant lung cancer
The mutation of tumor suppressor gene liver kinase B1 (LKB1) has a prevalence of about 20% in non–small cell lung cancer (NSCLC). LKB1‐mutant lung cancer is characterized by enhanced aggressiveness and immune escape and is associated with poor prognosis. Therefore, it is urgent to develop effective...
Autores principales: | Yang, Lujie, Zhang, Qin, Xiong, Yanli, Dang, Zhaoqian, Xiao, He, Chen, Qian, Dai, Xiaoyan, Zhang, Lei, Zhu, Jianwu, Wang, Dong, Li, Mengxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067398/ https://www.ncbi.nlm.nih.gov/pubmed/36459496 http://dx.doi.org/10.1111/cas.15677 |
Ejemplares similares
-
Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses
por: Zhang, Qin, et al.
Publicado: (2023) -
AMPK potentiation by LKB1 isoforms
por: Thibert, Chantal, et al.
Publicado: (2015) -
LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
por: Qu, Shuang, et al.
Publicado: (2022) -
Connecting LKB1 and AMPK links metabolism with cancer
por: Moore, Pete
Publicado: (2003) -
MLK3 Phophorylates AMPK Independently of LKB1
por: Luo, Lingyu, et al.
Publicado: (2015)